UC AKT.ANL. 12/24 RWE/ DE000HC7QNF1 /
| 2024-07-26 9:46:24 PM | Chg.+0.450 | Bid9:59:32 PM | Ask9:59:32 PM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 97.660EUR | +0.46% | 97.610 Bid Size: 70,000 |
97.760 Ask Size: 70,000 |
RWE AG INH O.N. | 32.00 - | 2024-12-31 | Call |
GlobeNewswire
06-25
Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guill...
GlobeNewswire
06-18
Truveta announces support for regulatory submissions to the FDA and global regulatory authorities
GlobeNewswire
06-12
RWE Announces Start of Site Investigation Campaign for its Canopy Offshore Wind Project off the Coas...
GlobeNewswire
06-11
RWE begins onsite construction on its first utility-scale solar project in Illinois to support rapid...
GlobeNewswire
06-05
Intuitive Announces FDA Clearance of Revised da Vinci Xi and X Labeling on Radical Prostatectomy
GlobeNewswire
06-04
Annexon Announces Positive Topline Results from Pivotal Phase 3 Trial for First-in-Class C1q Blockin...
GlobeNewswire
05-23
RWE signs two 15-year Power Purchase Agreements with Microsoft to supply clean energy from two onsho...
GlobeNewswire
05-20
RWE expands U.S. development portfolio with new project acquisitions across three states
GlobeNewswire
05-13
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
GlobeNewswire
05-02
Using clinical-led AI, Truveta expands clinical notes and medical images available to advance resear...
GlobeNewswire
04-25
Truveta delivers largest and most complete mother and child EHR dataset to advance healthcare
